Search

everythinglearnresearchcommunity

for

Search:↓

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Minoxidil is a primary treatment for hair loss but its exact working method is unknown.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Using old drugs for new uses can help treat rare immune deficiencies.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Bicalutamide may help treat female pattern hair loss.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that freeze-dried platelet-rich plasma shows promise for medical use but requires standardization and further research.

Apremilast shows promise for several skin conditions but needs more research.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Spironolactone might lower the chance of getting rosacea.